Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Central Securities Co. stock logo
CET
Central Securities
$48.40
+0.8%
$47.26
$40.24
$49.51
$1.40B0.8226,387 shs5,976 shs
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
$11.84
-0.3%
$11.46
$9.51
$15.30
$1.39B0.72804,198 shs13,761 shs
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$13.29
-1.6%
$12.70
$10.55
$15.90
$383.54M0.74103,922 shs12,771 shs
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
$13.27
-1.3%
$12.75
$10.18
$15.59
$1.25B0.97457,059 shs285,051 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Central Securities Co. stock logo
CET
Central Securities
0.00%+0.54%+2.98%+16.29%+8.91%
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
0.00%+0.51%+2.64%+14.37%-21.56%
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
0.00%+0.99%+5.25%+12.50%-13.53%
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
0.00%+0.68%+7.64%+15.42%-13.62%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Central Securities Co. stock logo
CET
Central Securities
N/AN/AN/AN/AN/AN/AN/AN/A
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
1.2585 of 5 stars
0.83.02.50.03.20.01.3
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/AN/AN/AN/AN/AN/AN/A
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
2.3805 of 5 stars
1.35.01.70.03.10.01.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Central Securities Co. stock logo
CET
Central Securities
0.00
N/AN/AN/A
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
1.50
Reduce$12.001.35% Upside
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
0.00
N/AN/AN/A
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
2.67
Moderate Buy$14.005.50% Upside

Current Analyst Ratings Breakdown

Latest HQL, CET, GSBD, and MFIC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/14/2025
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$16.00 ➝ $15.00
4/28/2025
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$12.00 ➝ $10.00
4/28/2025
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$14.00 ➝ $13.00
4/24/2025
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$13.50 ➝ $11.50
(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Central Securities Co. stock logo
CET
Central Securities
$296.20M4.73N/AN/AN/A
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
$434.37M3.20$2.18 per share5.43$13.41 per share0.88
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/AN/AN/AN/AN/A
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
$301.78M4.10$1.02 per share12.96$14.98 per share0.89
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Central Securities Co. stock logo
CET
Central Securities
N/AN/A0.00N/AN/AN/AN/A8/12/2025 (Estimated)
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
$62.87M$0.4526.316.47N/A12.38%15.05%6.64%8/7/2025 (Confirmed)
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/A0.00N/AN/AN/AN/AN/A
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
$98.82M$1.2410.778.29N/A33.21%10.66%4.52%8/11/2025 (Estimated)

Latest HQL, CET, GSBD, and MFIC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025Q2 2025
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
$0.37N/AN/AN/A$81.70 millionN/A
8/7/2025Q2 2025
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
$0.3950N/AN/AN/A$94.55 millionN/A
5/12/2025Q1 2025
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
$0.39$0.37-$0.02$0.32$82.49 million$78.70 million
5/8/2025Q1 2025
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
$0.43$0.41-$0.02$0.27$101.12 million$96.94 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Central Securities Co. stock logo
CET
Central Securities
$2.304.75%N/AN/AN/A
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
$1.2810.81%N/A284.44%N/A
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
$1.8914.23%N/AN/AN/A
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
$1.5211.45%N/A122.58%N/A

Latest HQL, CET, GSBD, and MFIC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/9/2025
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
quarterly$0.3211.7%6/30/20256/30/20257/28/2025
5/20/2025
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
quarterly$0.4313.82%5/22/20255/22/20256/30/2025
6/4/2025
Central Securities Co. stock logo
CET
Central Securities
quarterly$0.252.14%6/17/20256/17/20256/27/2025
5/7/2025
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
quarterly$0.3811.9%6/10/20256/10/20256/26/2025
5/24/2025
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
$0.0517.09%5/30/20256/2/20256/13/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Central Securities Co. stock logo
CET
Central Securities
N/AN/AN/A
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
1.21
1.39
1.39
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/AN/AN/A
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
1.39
5.98
5.98
CompanyEmployeesShares OutstandingFree FloatOptionable
Central Securities Co. stock logo
CET
Central Securities
628.94 million26.19 millionNot Optionable
Goldman Sachs BDC, Inc. stock logo
GSBD
Goldman Sachs BDC
N/A117.30 million117.15 millionOptionable
abrdn Life Sciences Investors stock logo
HQL
abrdn Life Sciences Investors
N/A28.87 million25.97 millionNot Optionable
MidCap Financial Investment Corporation stock logo
MFIC
MidCap Financial Investment
N/A93.30 million92.56 millionOptionable

Recent News About These Companies

Q1 2025 MidCap Financial Investment Corp Earnings Call

New MarketBeat Followers Over Time

Media Sentiment Over Time

Central Securities stock logo

Central Securities NYSE:CET

$48.40 +0.40 (+0.83%)
As of 07/18/2025 03:59 PM Eastern

Central Securities Corp. is a publicly owned investment manager. The firm invests in the public equity markets of the United States. It also invests on bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks and corporations. Central Securities Corp. was founded on October 1, 1929 and is based in New York City.

Goldman Sachs BDC stock logo

Goldman Sachs BDC NYSE:GSBD

$11.84 -0.03 (-0.29%)
As of 09:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Goldman Sachs BDC, Inc. is a business development company specializing in middle market and mezzanine investment in private companies. It seeks to make capital appreciation through direct originations of secured debt, senior secured debt, junior secured debt, including first lien, first lien/last-out unitranche and second lien debt, unsecured debt, including mezzanine debt and, to a lesser extent, investments in equities. The fund primarily invests in United States. It seeks to invest between $10 million and $75 million in companies with EBITDA between $5 million and $75 million annually.

abrdn Life Sciences Investors stock logo

abrdn Life Sciences Investors NYSE:HQL

$13.29 -0.21 (-1.59%)
As of 09:45 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. Abrdn Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

MidCap Financial Investment stock logo

MidCap Financial Investment NASDAQ:MFIC

$13.27 -0.18 (-1.34%)
As of 09:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MidCap Financial Investment Corporation (Former name Apollo Investment Corporation) is business development company and a closed-end, externally managed, non-diversified management investment company. It is elected to be treated as a business development company (BDC) under the Investment Company Act of 1940 (the 1940 Act) specializing in private equity investments in leveraged buyouts, acquisitions, recapitalizations, growth capital, refinancing and private middle market companies. It provides direct equity capital, mezzanine, first lien secured loans, stretch senior loans, unitranche loans, second lien secured loans and senior secured loans, unsecured debt, and subordinated debt and loans. It also seeks to invest in PIPES transactions. The fund may also invest in securities of public companies that are thinly traded and may acquire investments in the secondary market and structured products. It prefers to invest in preferred equity, common equity / interests and warrants and makes equity co-investments. It may invest in cash equivalents, U.S. government securities, high-quality debt investments that mature in one year or less, high-yield bonds, distressed debt, non-U.S. investments, or securities of public companies that are not thinly traded. It also focuses on other investments such as collateralized loan obligations (CLOs) and credit-linked notes (CLNs). The fund typically invests in construction and building materials, business services, plastics & rubber, advertising, capital equipment, education, cable television, chemicals, consumer products/goods durable and non-durable and customer services, direct marketing, energy oil & gas, electricity and utilities. The fund also invest in aerospace & defense, wholesale, telecommunications, financial services, hotel, gaming, leisure, restaurants; environmental industries, healthcare and pharmaceuticals, high tech industries, beverages, food and tobacco, manufacturing, media diversified & production, printing and publishing, retail, automation, aviation and consumer transport, transportation, cargo and distribution. It primarily invests in United States. It primarily invests between $20 million and $250 million in its portfolio companies and EBITDA with less than $75 million. The fund seeks to make investments with stated maturities of five to 10 years.